Skip to main content
release_alert
Welcome to the new Scholars 3.0! Read about new features and let us know what you think.
cancel
Journal cover image

Phencyclidine disposition after intravenous and oral doses.

Publication ,  Journal Article
Cook, CE; Brine, DR; Jeffcoat, AR; Hill, JM; Wall, ME; Perez-Reyes, M; Di Guiseppi, SR
Published in: Clin Pharmacol Ther
May 1982

[3H]-Phencyclidine (PCP) hydrochloride was given in intravenous (0.1 or 1 mg) or oral (1 mg) doses to male subjects. After 1 mg IV, drug and metabolites were recovered in urine (72.8 +/- 4.0% of dose), feces (4.7 +/- 0.9%), and perspiration. Fecal excretion was low (3.4 +/- 0.4%) after oral dosing and oral bioavailability was estimated at 72%. PCP comprised 16% of urinary radioactivity with 31% consisting of enzymatically hydrolyzable conjugates of hydroxylated metabolites. Both cis and trans isomers of 4-phenyl-4-(1-piperidinyl)cyclohexanol were found. Maximum average plasma PCP concentrations of 2.7 to 2.9 ng/ml were observed after oral and intravenous 1-mg doses. Blood/plasma ratios were approximately 1.0 and plasma binding was about 65%. Parent drug was found in saliva. Apparent terminal phase half-lifes averaged 21 +/- 3 hr (harmonic mean 17 hr, range 7 to 46 hr). The volume of distribution averaged 6.2 +/- 0.3 l/kg. Renal clearances were variable, but the average was 9% of the total clearance. Thus, PCP is cleared principally by metabolism.

Duke Scholars

Published In

Clin Pharmacol Ther

DOI

ISSN

0009-9236

Publication Date

May 1982

Volume

31

Issue

5

Start / End Page

625 / 634

Location

United States

Related Subject Headings

  • Saliva
  • Protein Binding
  • Phencyclidine
  • Pharmacology & Pharmacy
  • Male
  • Kinetics
  • Injections, Intravenous
  • Hydrogen-Ion Concentration
  • Humans
  • Female
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Cook, C. E., Brine, D. R., Jeffcoat, A. R., Hill, J. M., Wall, M. E., Perez-Reyes, M., & Di Guiseppi, S. R. (1982). Phencyclidine disposition after intravenous and oral doses. Clin Pharmacol Ther, 31(5), 625–634. https://doi.org/10.1038/clpt.1982.87
Cook, C. E., D. R. Brine, A. R. Jeffcoat, J. M. Hill, M. E. Wall, M. Perez-Reyes, and S. R. Di Guiseppi. “Phencyclidine disposition after intravenous and oral doses.Clin Pharmacol Ther 31, no. 5 (May 1982): 625–34. https://doi.org/10.1038/clpt.1982.87.
Cook CE, Brine DR, Jeffcoat AR, Hill JM, Wall ME, Perez-Reyes M, et al. Phencyclidine disposition after intravenous and oral doses. Clin Pharmacol Ther. 1982 May;31(5):625–34.
Cook, C. E., et al. “Phencyclidine disposition after intravenous and oral doses.Clin Pharmacol Ther, vol. 31, no. 5, May 1982, pp. 625–34. Pubmed, doi:10.1038/clpt.1982.87.
Cook CE, Brine DR, Jeffcoat AR, Hill JM, Wall ME, Perez-Reyes M, Di Guiseppi SR. Phencyclidine disposition after intravenous and oral doses. Clin Pharmacol Ther. 1982 May;31(5):625–634.
Journal cover image

Published In

Clin Pharmacol Ther

DOI

ISSN

0009-9236

Publication Date

May 1982

Volume

31

Issue

5

Start / End Page

625 / 634

Location

United States

Related Subject Headings

  • Saliva
  • Protein Binding
  • Phencyclidine
  • Pharmacology & Pharmacy
  • Male
  • Kinetics
  • Injections, Intravenous
  • Hydrogen-Ion Concentration
  • Humans
  • Female